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Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, CaliforniaABSTRACT Recent experiments to derive a thermally stable mutant of turkey beta-1-adrenergic receptor (b1AR) have shown
that a combination of six single point mutations resulted in a 20C increase in thermal stability in mutant b1AR. Here we have
used the all-atom force-ﬁeld energy function to calculate a stability score to detect stabilizing point mutations in G-protein coupled
receptors. The calculated stability score shows good correlation with the measured thermal stability for 76 single point mutations
and 22 multiple mutants in b1AR. We have demonstrated that conformational sampling of the receptor for various mutants
improve the prediction of thermal stability by 50%. Point mutations Y227A5.58, V230A5.61, and F338M7.48 in the thermally stable
mutant m23-b1AR stabilizes key microdomains of the receptor in the inactive conformation. The Y227A
5.58 and V230A5.61 muta-
tions stabilize the ionic lock between R1393.50 on transmembrane helix3 and E2856.30 on transmembrane helix6. The mutation
F338M7.48 on TM7 alters the interaction of the conserved motif NPxxY(x)5,6F with helix8 and hence modulates the interaction of
TM2-TM7-helix8 microdomain. The D186-R317 salt bridge (in extracellular loops 2 and 3) is stabilized in the cyanopindolol-
bound wild-type b1AR, whereas the salt bridge between D184-R317 is preferred in the mutant m23. We propose that this could
be the surrogate to a similar salt bridge found between the extracellular loop 2 and TM7 in b2AR reported recently. We show that
the binding energy difference between the inactive and active states is less in m23 compared to the wild-type, which explains the
activation of m23 at higher norepinephrine concentration compared to the wild-type. Results from this work throw light into the
mechanism behind stabilizing mutations. The computational scheme proposed in this work could be used to design stabilizing
mutations for other G-protein coupled receptors.INTRODUCTIONObtaining three-dimensional structural information for
membrane-bound G-protein coupled receptors (GPCRs) is
of utmost value in designing drugs. Challenges such as
obtaining sufficient quantity of the protein and stabilizing
purified proteins in detergents have been overcome during
the past decade, leading to the recent surge in GPCR struc-
tures (1,2). The structures of b-adrenergic receptors have
been solved by attaching an antibody (3), or the T4L lyso-
zyme in the intracellular loop (4), or by deriving thermally
stable mutants that are stable in detergents (5). Serrano-
Vega et al. (6) derived thermally stable mutant of turkey
b1AR with six mutations, from several stabilizing single
point mutations, for which Warne et al. (5) have obtained
the crystal structure. This mutant was found to be more stable
in detergents than the corresponding wild-type receptor,
and also mutations that increase the thermal stability of the
receptor were required for obtaining a high-resolution crystal
structure of b1AR. Understanding of the mutant behavior
and the origin of the stability of the mutants would allow
us to incorporate these principles into a computational design
algorithm, which can then be used in conjunction with exper-
iments to design mutants for other class-A GPCRs in protein
purification and biophysical experiments.
In the thermal stability measurement experiments per-
formed by Serrano-Vega et al. (6), single point mutationsSubmitted January 7, 2010, and accepted for publication April 16, 2010.
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0006-3495/10/07/0568/10 $2.00of 318 residues, mostly in the transmembrane (TM) region
of a truncated version of the turkey b1AR containing resi-
dues 34–424 (represented as b1AR34-424), were tested for
improved thermal stability with respect to the wild-type.
They defined the stability quotient for the single mutants as
the percent stability of the mutants after heating the receptor
for 30 min at 32C, normalized to the b1AR wild-type values
at 50%. For multiple mutants, a measure Tm was defined as
the temperature at which the functional binding dropped to
50% of unheated control (6). The wild-type b1AR had an
apparent Tm of 32
C. To identify the mutation sites, the
residue at each position was mutated to an alanine, or a
leucine if an alanine was already present in that position.
Eighteen single mutations that led to the best increase in
thermal stability were identified. Subsequently, by combining
up to a maximum of five single mutations in random, mutants
were designed and tested for increased stability. Among these
multiple mutants, one mutant labeled m10-8, which had the
highest thermal stability and good expression level in Escher-
ichia coli, was selected for further mutagenesis experiments
(6). Mutations in m10-8 were modified by either adding or
replacing the existing mutations with other single mutations
that showed increased thermal stability. This led to engi-
neering m23-b1AR that was stable enough to be crystallized.
The goal of our work is to understand the role of the muta-
tions in reshaping the potential energy landscape of the
b1AR, and its relationship to the thermal stability.
Computational strategies have previously been developed
and applied extensively to measure the change in proteindoi: 10.1016/j.bpj.2010.04.075
TABLE 1 Table of mutants, their mutations, and their melting
temperatures
Mutant Mutations Tm(
C)
m19 R68S, M90V, Y227A, V230A, F327A, F338M 49
m20 R68S, M90V, V230A, A282L,* F327A, A334L 49
m23 R68S, M90V, Y227A, A282L,* F327A, F338M 52
*Mutation in the loop, which is missing in our model.
Stability of b1AR Mutants 569stability due to mutations, and to design proteins for water-
soluble globular proteins (7–12). There are two important
aspects to be considered for computational protein stability
calculations: robust conformational sampling, and an appro-
priate energy function for stability measurement. The energy
function is used to calculate the change in stability arising
from a mutation. Conformational sampling of the protein
has been shown to capture the effect of subtle structural
changes caused by mutations, and to enhance the accuracy
of computational predictions (13). Here we have designed
a computational method suitable for identifying stabilizing
mutations in membrane proteins.
In this work, we have used an all-atom force field energy
function in conjunction with systematic coarse-grain confor-
mational sampling using the LITiCon method (14,15) to
study the effect of mutations on the thermal stability of
b1AR. We have calculated the stability of single point and
multiple point mutants for various experimentally designed
mutants of b1AR (16). We have further analyzed the poten-
tial energy surface of the wild-type b1AR and the most stable
mutant m23-b1AR. Although the wild-type receptor shows
flexibility because of the possible degenerate energy states
in the inactive conformation, this degeneracy is broken in
the m23-b1AR and one of the inactive states is favorably
stabilized by the mutations. The six point mutations made
in m23-b1AR lead to stabilization of functional microdo-
mains like the ionic lock between TM helices 3 and 6 and
the aromatic interaction between the NPxxY(x)5,6F motif
on TM7 and helix8 (17). Using the LITiCon method, we
have also studied the effect of agonist binding on the
m23-b1AR and the wild-type b1AR conformations. We
found that norepinephrine-bound m23-b1AR shows smaller
difference in binding energy between inactive and active
state conformations compared to the wild-type b1AR. In
addition, the salt bridge network involving R317 (extracel-
lular loop 3) and D184/D186 (extracellular loop 2) is weak-
ened upon norepinephrine binding in both wild-type and
m23-b1AR receptors. We hypothesize that weakening of
this salt bridge could represent a new activation switch in
b1AR.METHODS
Packing the receptor structure in lipid bilayer
The receptor structures for the wild-type and mutant b1AR were prepared in
explicit lipid and water as follows. The three-dimensional structure of the
mutant m23-b1AR (PDB code: 2VT4) with antagonist cyanopindolol bound
was used as the starting point for all the structures used in this study. This
crystal structure does not have the intracellular loop 3 or the C-terminus resi-
dues beyond residue 359 resolved, and we used it as such for the computa-
tions. Appropriate residues in the m23 mutant structure were mutated using
VMD 1.8 (18) to generate the wild-type, m19, and m20 mutant structures
(the mutated positions and residues are shown in Table 1). Hydrogen atoms
were added and lipid packing was done using VMD.
The following procedure was used for packing lipid bilayer for the wild-
type, m23, m20, and m19-b1AR mutant structures. The receptor was packedin 174 palmitoyl-oleoyl phosphatidylcholine lipid molecules, 12,571 water
molecules, and sufficient Naþ and Cl ions to neutralize the system. The
simulation box dimension containing the lipid membrane layer is ~80 A˚
in length, 80 A˚ in width, and 100 A˚ in height. The packing of the lipid
bilayer and water was optimized in three stages of equilibration using
NPT dynamics at 300 K and 1 atm using the NAMD (19), CHARMM22
(for proteins), and CHARMM27 (for lipids) force fields (20,21). The molec-
ular dynamics was performed with 2-fs timestep along with SHAKE algo-
rithm. Periodic boundary conditions were used with particle-mesh Ewald
method, and a 12 A˚ nonbond cutoff. In the first stage, all but the lipid tail
atoms were kept fixed and lipid tails were allowed to pack for 0.5 ns. This
introduces disorder in the lipid tails, and prevents distorting the protein
during production runs. In the second stage, the receptor was kept fixed
and the whole of lipid and water was allowed to equilibrate for 0.5 ns.
In the third stage, the receptor was subject to a harmonic constraint and
was allowed to relax with the lipids and water. The final conformation of
the receptor packed in the membrane environment was used for conforma-
tional sampling and molecular dynamics (MD) simulation.Conformational sampling of the receptors
using LITiCon method
We have used the LITiCon computational method (14–16) to sample the
change in the receptor backbone and side-chain conformations in the TM
region upon mutation in explicit lipid bilayer and water. The LITiCon
method involves systematic spanning of the receptor conformations
involving the helical rotations. We have performed simultaneous rotations
of TM helices 1, 2, 5, and 7, where the mutations are present, and TMs 3,
5, and 6 to investigate TM3-TM6 salt bridge, over a range of 30 to 30
in increments of either 5 or 10. For each of the rotated conformations, side
chains were reassigned using SCWRL3.0 (22) and the resulting structure was
energy-minimized using NAMD for 1000 steps, until the structure reaches
a line-minimizer gradient bracket under 30 units. Subsequently the potential
energy of the receptor was calculated, using the all-atom NAMD/CHARMM
energy function. The LITiCon procedure measures the enthalpy component
of the free energy for different receptor conformations, and can include the
effect of explicit solvent on the receptor conformation and energy.
The potential energy surface thus calculated for the conformational
ensemble of m23-b1AR structure with and without receptor-lipid interaction
is shown in Fig. S1 in the Supporting Material. As seen from these figures,
the receptor-lipid interaction adds an offset to total interaction energy
without affecting the qualitative features of the potential energy surface.
However, it is possible that the lipid would affect the receptor potential
energy if the lipid bilayer conformation is optimized in its packing for every
receptor conformation sampled using MD or Monte Carlo simulations, but
that is computationally formidable. As the lipid interaction did not change
the qualitative nature of the receptor energy landscape, from here onwards
we make an approximation and perform our LITiCon calculations in the
absence of the lipids.Calculation of the stability score for mutants
A set of 128 receptor conformations close to the initial state was generated
for the wild-type b1AR using LITiCon, by rotating all the TM helicesBiophysical Journal 99(2) 568–577
570 Balaraman et al.by55. The bonded and nonbonded energy for each of the 128 conforma-
tions with all-atom force-field function in CHARMM22 was calculated for
the wild-type receptor. Then for each of the 76 single point mutations (omit-
ting the four different mutations on residue 282 present in the intracellular
loop 3, IL3 that is not resolved in the crystal structure) and 22 multiple
mutants derived by Serrano-Vega et al. (6), the 128 conformations generated
for the wild-type b1AR were mutated using SCWRL 3.0, and the atoms in
the 5 A˚ radius from the mutated residue were minimized in potential energy
using conjugate gradient minimization. At the end of this procedure, the
bonded and nonbonded interaction energies for the receptor-ligand system
were calculated using NAMD. Because the mutants have different numbers
of atoms compared to the wild-type, we consider only the difference in the
nonbond energy and torsional energy in calculating the stability difference
between the wild-type and the mutants.
We have used two different energy functions to calculate the stability of
the mutations, ETM for the mutations in the TM regions that are hydro-
phobic, and Eloops for those in the extracellular or intracellular loops that
are largely polar. The energy function is defined as
Eloops ¼ EvdWðprotein proteinÞ þ EvdWðprotein ligandÞ
þEelecðprotein proteinÞ þ Eelecðprotein ligandÞ
þ EtorsionðproteinÞ
ETM ¼ EvdWðprotein proteinÞ þ EvdWðprotein ligandÞ
þ EtorsionðproteinÞ: (1)
The EvdW(protein-protein) and EvdW(protein-ligand) are the van der Waals
(vdW) component of the protein-protein and protein-ligand interaction,
respectively. Eelec(protein-protein) is the electrostatic component of the
protein interactions and Eelec(protein-ligand) is the protein-ligand electro-
static interactions, both calculated with a constant dielectric of 40, and
Etorsion(protein) is the torsional component of the protein energy. Because
the mutations in the TM regions are predominantly hydrophobic/ hydro-
phobic, the use of vdW component for nonbond interaction captures the
contribution to stability from hydrophobic packing, whereas the electrostatic
component was found to have less effect on the change in stability. Also in
the TM region, the accurate estimation of the electrostatic interaction
needs to account for anisotropic dielectric environment inside the protein
core. The electrostatic interaction was neglected in energy function for muta-
tions in the TM regions to avoid false predictions arising from inaccuracies
in its estimation. As the loop regions are predominantly polar, we have
included electrostatic interactions as well to the energy function for muta-
tions in the loop regions. The TM prediction by MEMBSTRUK 4.0 (23)
was used to demarcate residues into TM and loop regions.
The value of the energy function mentioned above is computed for
different conformations generated for each mutation. The minimum energy
conformation is selected for wild-type and mutant from the ensemble, and
the stability score is calculated as the difference of the minimum energy
for the mutant and the wild-type:
Stability score ¼ Min½Ewild Min½Emutant: (2)
A positive (negative) value of the stability score implies increase
(decrease) in stability. In the calculations, stability score with an absolute
value less than a cutoff value of 1 kcal/mol is ignored. The stability score
is an approximate measure of change in free energy induced by the mutation
DDGwild/mut ¼

Gfmut  Gfwild
 Grmut  Grwild

; (3)
where the superscripts f/r represent folded/reference state free energies. Here
we assume that the internal (bond, angle) energies of the reference extended
state and the final folded state cancels out for both the wild-type and the
mutant. Further, we have assumed that the difference in nonbonded energies
for the reference extended state between the wild-type and the mutant is
negligible, assuming that the side chains are fully extended.Biophysical Journal 99(2) 568–577Details of the molecular dynamics simulations
We have also used all-atom MD simulations to study the effect of mutations
on the microdomain structure and stability (17). The all-atom MD simula-
tions were performed using receptor structure packed and equilibrated in
lipid bilayer and the program NAMD. The production run for the MD simu-
lations were done using the NPT ensemble at 1 atm and 305 K. Nonbond
force cutoff of 12 A˚ was used with particle-mesh Ewald method for electro-
statics along with SHAKE algorithm to constrain bond vibrations. The MD
simulation run was done for 100 ns each for the wild-type, m23, m20, and
m19 mutant structures. The RMSD in coordinates for the wild-type and m23
receptors from the MD simulation trajectories is shown in Fig. S4.Methods used to study norepinephrine binding
to m23 and wild-type b1AR
To study the effect of agonist binding to the wild-type and mutant m23-
b1AR receptors, we docked the norepinephrine molecule in the crystal struc-
ture of m23-b1AR and the wild-type b1AR using the GLIDE docking
program (23). The docked pose that best satisfied the knownmutation results
for norepinephrine binding in b-adrenergic receptors was chosen. To calcu-
late the ligand-stabilized conformational changes effected by norepinephrine
binding, we used the LITiCon method (14–16) on both the m23-b1AR and
wild-type receptors. The TM helices 3, 5, and 6 were rotated between 50
and þ50 in 10 increments. In our previous studies on b2AR (14–16), we
found helices 3, 5, and 6 to undergo substantial conformational changes in
the presence of norepinephrine and epinephrine, and hence we selected these
helices for conformational scanning of norepinephrine-bound b1AR. As the
ligand can rearrange in the binding site in response to receptor flexibility, we
redocked the ligand at every step of LITiCon using the docking program
GLIDE (23). The local minima in the resulting energy landscapes were iden-
tified, clustered, and sorted by total number of interhelical hydrogen-bond
(HB) and ligand-receptor HB and then by binding energy. The final ligand
stabilized receptor structural model was selected based on low binding
energy and a high number of HBs. We have used this method to predict
the norepinephrine stabilized conformation in both m23 and wild-type
b1AR. The norepinephrine-bound state in the wild-type was validated
agonist known point mutation studies in b-adrenergic receptors (24–27)
(Fig. S7). This conformation is the predicted active state model for b1AR.
RESULTS
Stability score predicts the thermal stability
of the single mutants
We have calculated the stability score (defined in Methods)
for 76 single mutants of b1AR presented in Serrano-Vega
et al. (6). To investigate the importance of conformational
sampling in measuring thermal stability, the stability scores
were calculated from a single starting conformation as well
as an ensemble of conformations generated by LITiCon.
It is seen from Fig. 1 a that 50% of the mutations are
predicted in accordance with the experimental stability mea-
surements, when conformational sampling is not included.
Conformational sampling improves this prediction substan-
tially to 75% as shown in Fig. 1 b. Some of the mutations
that showed increase in thermal stability and were predicted
correctly only with conformational sampling include resi-
dues at position I551.46, M902.53, G982.61, I1293.40, S151,
L2215.52, and A2345.65. Here we have used the class-A
GPCR residue numbering system formulated by Ballesteros
and Weinstein (28). (In this numbering system, the first
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FIGURE 1 Pie chart showing the percentage
correctness of predictions of the thermal stability
of various single mutations using the stability score
(a) without and (b) with conformational sampling.
The graph classifies the predictions into correct
positives, correct negatives, false positives, and
false negatives.
Stability of b1AR Mutants 571number refers to the TM helix in which the residue is located
and the second number is the position of the residue with
respect to the most conserved residue on that helix among
many class-A GPCRs. The most conserved residue takes
the number 50 on each helix.) Barring the exception of
S151, all the other mutation residue positions are in the
TM region of the receptor. Thus we see that the variation/
sampling in the backbone and side-chain conformations
upon mutation is important for residues in the TM regions.
The LITiCon method robustly samples these conformational
changes upon mutation, and hence yields higher accuracy in
predicting mutations.FIGURE 2 Plot of stability score versus Tm for 22 mutants of b1AR is
shown with an average expected error of 1 Kcal/mol (points). The data is
shown with a linear fitted line having R ¼ 0.86.Stability score calculations for multiple mutants
Further, the stability score has been calculated for 22 mul-
tiple mutants formed by combining various positive single
mutations that showed substantial synergistic increase in
thermal stability. We have calculated the stability score for
each of the 22 mutants using the procedure described in
Methods. A comparison of the stability score and the Tm
(explained in the Introduction) from experiments by Serrano-
Vega et al. (6) is shown in Fig. 2. The calculated stability
score and the Tm from experiments are in good agreement
with an R-value of 0.86. The stability score correctly distin-guishes the less stable mutants from the more stable ones.
The error estimate in the stability score is ~1–2 kcal/mol,
which accounts for the spread observed from the linear
fitted line.Insight into thermal stabilization by mutants
To investigate the reshaping of the potential energy surface
of the receptor by mutations, we performed conformationalBiophysical Journal 99(2) 568–577
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FIGURE 3 Cross section of the potential energy
landscape in the TM3 and TM6 rotation angle space
for (a) wild-type and (b) m23 mutant. The salt-
bridge-favoring and salt-bridge-broken minima
have been illustrated. (c) The energy landscape in
the TM5-TM6 rotation space for the wild-type
illustrates the lipid-facing and core-facing minima
for Y2275.58. The potential energy minimum
marked ‘‘2’’ has the R1393.50-E2856.30 salt bridge
broken, whereas the minimum marked ‘‘1’’ has
R1393.50-E2856.30 salt bridge partially formed. (d)
The salt-bridge-broken and salt-bridge-favoring
conformations of wild-type from the two minima
in panel a are shown. The lipid-facing and core-
facing minima of the wild-type from panel c are
shown here. Structure snapshots were generated
using PyMOL from DeLano Scientific (San Fran-
cisco, CA).
572 Balaraman et al.sampling using LITiCon for the wild-type and three mutants
m19, m20, and m23 over a wider helical rotation angle range
of30 toþ30 in increments of 10. To understand the role
of modulation of helical kinks in the stability of the mutant
receptors we also performed an all-atom MD simulation
(for 100 ns each).Effect of Y227A5.58 and V230A5.61 mutations
on the receptor stability
The Y227A5.58 mutation shows an increase of 8C in the Tm,
which is the maximum increase among all of the single muta-
tions tested in b1AR34-424 (6). The other single mutants typi-
cally showed an increase of only 1–3C. To understand the
effect of Y227A5.58 mutation on the receptor stability, we
calculated the potential energy surface with conformational
sampling using LITiCon for rotations of TM3, TM5, and
TM6 that interact closely with the mutation site on TM5.
Fig. 3 shows the cross section of the receptor potential
energy surface for the wild-type, and the mutant m23, as
a function of rotations of TM3 and TM6. The TM3-TM6
energy landscape (Fig. 3 a) for the wild-type exhibits two
distinct potential energy minima, and the corresponding
conformations are shown in Fig. 3 d. One of the minimum
energy conformation favors the formation of salt bridge or
the ionic lock between R1393.50 and E2856.30, and the other
conformation does not. The mutant m23, on the other hand,
has only one potential energy minimum in the TM3-TM6
rotation space (Fig. 3 b), and this corresponds to R1393.50Biophysical Journal 99(2) 568–577and E2856.30 in a salt-bridge-favoring orientation (not
shown). We explain below how this difference in the poten-
tial energy surface for the wild-type and the mutant m23 is
caused by the Y227A5.58 mutation on TM5. Y2275.58 in
the wild-type exhibits two conformations (Fig. 3, c and e),
one facing the lipids and another sandwiched between
TM3 and TM6. This has also been observed in the inactive
and partially active state crystal structures of rhodopsin
and opsin, respectively, where the Y2235.58 (PDB accession
1U19) faces the lipid bilayer in rhodopsin, and the Y2235.58
is wedged between TM3 and TM6 breaking the ionic lock
between R1353.50 and E2476.30 in the opsin structure (PDB
accession 3CAP) (29).
Based on the discussion above, we hypothesize that
the Y227A5.58 mutation in m23 (and V230A5.61 in other
mutants) favors the formation of the R1393.50-E2856.30 ionic
lock and stabilizes the inactive state conformation. This
hypothesis has been further verified from the data col-
lected using 100-ns MD simulation of the wild-type and
the mutants. Fig. 4 shows the ionic-lock distance between
R1393.50 and E2856.30 for the wild-type and m23-b1AR.
In the wild-type, a stable salt bridge is not formed between
TM3 and TM6 during 100 ns of the MD simulations. This
is because the Y2275.58 flips inwards and wedges between
TM3 and TM6 (data not shown) during the dynamics.
In the mutant m23, although not observed in the crystal
structure, a stable ionic lock is formed between R1393.50
and E2856.30 during the MD simulations after an initial equil-
ibration phase. These results are similar to the observation
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FIGURE 4 Salt-bridge N-O distance between R1393.50 and E2856.30 is
shown for (a) wild-type and the (b) mutant m23. Ideal N-O distance of
3.2 A˚ is shown in shaded dashed line.
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FIGURE 5 Potential energy landscape shown as a function of TM1 and
TM7 rotations for (a) wild-type and (b) m23. (c) Representative snapshots
showing conformations of Y3437.53-F3497.59 interaction in wild-type and
m23. Structure snapshots generated using PyMOL from DeLano Scientific.
Stability of b1AR Mutants 573made during MD simulations of human b2AR (30). The
ionic lock between TM3 and TM6 thus contributes to the
stability of the inactive state conformation of the mutant
m23.
Mutant m20 has the V230A5.61 mutation instead of
Y227A5.58 on TM5, whereas mutant m19 has both
V230A5.61 and Y227A5.58 mutations on TM5. Both m19
and m20 mutants showed stabilization of the R1393.50-
E2856.30 salt bridge (Fig. S2) supporting the hypothesis
that Y227A5.58 and V230A5.61 mutations increase the sta-
bility of the inactive state by stabilizing the TM3-TM6 ionic
lock therefore conferring thermal stability.Effect of F338M7.48 mutation on stability
To understand the contribution of F338M7.48 mutation to the
receptor stability, we have analyzed the potential energy
landscape as a function of TM1-TM2-TM7 rotation. In Fig. 5,
a and b, the energy landscape of the wild-type and mutant
m23 are shown as a function of TM1 and TM7 rotation
angles. There are two interesting differences between the
energy landscapes shown for wild-type and m23:
1. The energy minimum is deeper in the m23 by 20 kcal/mol.
2. The minimum energy for m23 is located at 10 rotation
of TM7, whereas it is at 10 rotation of TM7 for the
wild-type.
These observations have implication in modulating the
interaction between the Y3437.53 (part of the NPxxY(x)5,6F
motif) and F3497.59 and hence the motion of the TM7-helix8
microdomain. Representative conformations of Y3437.53-
F3497.59 interaction in the wild-type and m23 from MD
simulations are shown in Fig. 5 c. In the mutant m23, the
aromatic rings in Y3437.53 and F3497.59 are in a p-p stacking
conformation, whereas in the wild-type the p-p stacking is
broken. This is indicative of a stronger Y3437.53-F3497.59
interaction in m23 in comparison to the wild-type, thusleading to an increase in thermal stability of the inactive state
in m23.
The conserved NPxxY(x)5,6F motif found in class-A
GPCRs connects TM7 with helix8 in the cytoplasmic side.
In rhodopsin, the Y3067.53 forms a p-p stacking with
F3137.59 in the inactive state, and this interaction is proposed
to be broken during activation (29). Mutation results
have shown that elimination of Y-F interaction in the
NPxxY(x)5,6F motif in rhodopsin leads to an increase in
constitutive activity (31). Microsecond timescale simulations
of rhodopsin have shown that interaction of the microdo-
mains N3027.49-Y3067.53 and Y3067.53-F3137.59 are impor-
tant in stabilizing the inactivelike conformation of rhodopsin
(17). The signatures of activation revealed from their dynam-
ical simulations include reduction in the TM7-helix8 angle
from an initial near-perpendicular conformation, and an
increase in the TM2-helix8 distances.
We hypothesize that the F338M7.48 mutation directly
affects the interaction of the N3397.49-Y3437.53 and the
Y3437.53-F3497.59 microdomains and hence modulates the
movement of TM1-TM2-TM7-helix8 bundle. The TM7-
helix8 angle and TM2-helix8 distance from MD simulations
is shown in Fig. 6, a–d. Details of the calculation of the
TM7-helix8 angle are presented in the Supporting Material.
We observe from the MD simulations that the TM7-helix8
angle is stabilized close to perpendicular values in the mutant
m23 (Fig. 6 b). This correlates well with reduction in
TM2-helix8 distance in m23, and is stabilized at 15.5A˚
(Fig. 6 d). The TM7-helix8 angle in the wild-type decreases
below 70 (Fig. 6 a) and TM2 and helix8 move apart, stabi-
lizing at 16.5 A˚ (Fig. 6 c). This correlation in the TM7-helix8
bend with TM2-helix8 distance is similar to the observations
made from MD simulations of rhodopsin (17). Thus, m23Biophysical Journal 99(2) 568–577
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FIGURE 6 TM7-helix8 bend-angle in (a) wild-type and (b) mutant m23
as a function of time. The shaded dashed line marks the perpendicular angle.
The TM2-helix8 intracellular distance measured as the Ca-Ca distance
between T762.39-A3527.62 for the (c) wild-type and (d) m23. The shaded
dashed line marks 15.5 A˚.
574 Balaraman et al.does not exhibit the signatures of active state in the TM2-
TM7-helix8 microdomain that is otherwise seen in the
wild-type. Mutant m19 (with the F338M7.48 mutation) also
showed movement in the TM7-helix8 domain similar to
m23, whereas m20 (which does not have the F338M7.48
mutation) did not (Fig. S3). This asserts the importance of
F338M7.48 in stabilizing the TM2-TM7-helix8 domain and
hence inactive state in the mutants.Effect of other mutations on thermal stability
TM1 has the R68S1.59 mutation that stabilizes the receptor.
We speculate that R681.59, which, in close proximity to the
carboxy terminus, makes a salt bridge with one of the acidic
residues E425, E427, E460, or D461 in the carboxy terminus
of the receptor that has been truncated in the thermal stabili-
zation experiments. Truncation of the carboxy terminus for
crystallization could have destabilized the salt bridge formed
by R681.59, which is stabilized in the mutants by the R68S1.59
mutation. The mutations M90V2.53, F327A7.37, and
F334L7.44 are located on TM2 and TM7, respectively. These
mutations confer a stability of 1–3C in temperature, and
show an improvement in the enthalpy component in ourBiophysical Journal 99(2) 568–577calculations. These mutations possibly lead to better side-
chain packing in the receptor, and hence contribute to an
increase in stability.Effect of thermostable mutations on the loop
conformations
In a recent work, Bokoch et al. (32) have shown that in
human b2AR, agonists, neutral antagonists, and inverse
agonists stabilize different conformations of the D192-
K305 salt bridge connecting extracellular loops 2 and 3.
Therefore, we investigated whether a similar salt bridge
could be found among the extracellular loops of b1AR.
Turkey b1AR has an acidic residue (D322
7.32) at the homol-
ogous position of the basic residue K3057.32 in b2AR and
hence, the salt bridge analogous to the one found in b2AR
is missing in b1AR. However, we identified an alternate
salt bridge connecting extracellular loop 2 and extracellular
loop 3 involving residues D184 and R317 in the crystal
structure of the m23-b1AR. The D186 on extracellular
loop 2 is also close to R317, but does not form a salt bridge.
As shown in the multiple sequence alignment (Fig. S5), resi-
dues D184, D186, and R317 are conserved among b1 recep-
tors across different species, suggesting the importance of
this salt bridge in modulating receptor functionality. During
the MD simulations of wild-type b1AR bound to cyanopin-
dolol, the salt-bridge partner of R317 shifted from D184 to
D186 and remained stable throughout the simulation
(Fig. 7 a). In contrast, during the MD simulation of the
mutant m23, two alternating salt bridge conformations,
D186-R317 and D184-R317, were stabilized (Fig. 7 b).
Interestingly, the other mutants m20 and m19 also showed
a propensity to form both salt bridges during their respective
MD simulations, although favoring D184-R317 over D186-
R317 salt bridge. The variation in distance between the gua-
nidinium nitrogen of R317 and carboxylic oxygen of D184
and D186 in the wild-type and m23 mutant receptors is
shown in Fig. 7, c and d, respectively. During the MD simu-
lation of wild-type receptor (Fig. 7 c), the D184-R317 salt
bridge is disrupted within 10 ns (distance increases to 4–5 A˚)
and the D186-R317 salt bridge is formed in its place
(distance 2.8 A˚). In the m23 receptor (Fig. 7 d), the D184-
R317 salt bridge is stable until 40 ns, when this salt bridge
is disrupted and an alternate salt bridge is formed between
R317 and D186. Then after 80 ns, the D186-R317 salt bridge
is disrupted and the D184-R317 salt bridge is reformed. As
the wild-type receptor forms D186-R317 salt bridge only
in the MD simulations, we propose that the disruption of
the D186-R317 salt bridge in a mutation experiment could
destabilize the wild-type receptor. In the m23 mutant,
because both D184-R317 and D186-R317 salt bridges are
favorably formed, the effect of disrupting one of the salt
bridges could be compensated for by the formation of the
other salt bridge and thus lead to increased stability of the
m23 mutant over wild-type b1AR.
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FIGURE 7 Representative snapshots of confor-
mation of salt bridge between extracellular loop
2 and 3 (a) linking D186-R317 in wild-type, (b)
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We calculated the probability of occurrence of the R317-
D184/D186 salt bridges in the inactive and predicted norepi-
nephrine-bound active states of both wild-type and m23
b1AR using the side-chain reassignment program SCREAM
(33). In both wild-type and m23 receptors, the side chains of
R317 and D186 showed 63% and 85% reduction in salt-
bridge population in the predicted active state compared to
the cyanopindolol bound inactive state. In addition, in the
predicted active state of the m23 mutant, the salt bridge
between D184 and R317 was completely disrupted (100%
reduction in salt-bridge population compared to inactive
state). Thus, the predicted active state models of both wild-
type and m23 b1AR show higher propensity for breaking
the R317 to D184 or D186 salt bridge compared to the inac-
tive state. This result is similar to the observation made by
Bokoch et al. (32) in b2AR, where they used NMR experi-
ments to show that the salt bridge between K305 and
D192 in b2AR was disrupted on binding to agonist formo-
terol, whereas this salt bridge was preserved in the unli-
ganded and antagonist-bound receptors. Thus, the salt bridge
involving R317 and D184/D186 in b1AR could act as a
possible conformational switch-mediating, agonist-induced
b1AR activation.Effect of thermal stable mutations on agonist
binding on m23 mutant compared
to the wild-type b1AR
We investigated the effect of thermostable mutations on
agonist binding by computing the binding energy landscapes
of the agonist norepinephrine bound to the wild-type and
m23 mutant of b1AR (Fig. S6) using LITiCon method asdescribed in Methods. Both wild-type and m23-b1AR recep-
tors show a wide binding energy trough near the crystal
conformation and another binding-energy minimum that is
predicted to be the norepinephrine-stabilized state in our
calculations. The calculated binding energy of norepineph-
rine in the predicted active state of the wild-type b1AR is
5 kcal/mol better than its binding energy in the inactive
state, whereas the same difference in m23-b1AR is only
0.5 kcal/mol. Thus, binding of norepinephrine to the wild-
type b1-AR shifts the inactive4 active equilibrium toward
the active state. The m23 receptor has less constitutive
activity compared to the wild-type. In addition, due to small
difference in binding energy between the inactive and the
active states, low concentrations of norepinephrine does not
shift the equilibrium toward the active state in m23. This
shows that the m23 receptor requires higher concentration
of norepinephrine for receptor activation. Thus, our observa-
tions are in agreement with the results from competition
binding with the antagonist dihydroalprenolol (DHA), where
norepinephrine displaced radiolabeled DHA at a higher
concentration in m23 compared to wild-type (6). The reason
for the lower difference in binding energy between the inac-
tive and active states in m23 is not evident from the ligand-
residue interaction energies calculated for residues in the
binding site (residueswithin 5 A˚ of the ligand). The difference
in binding energy is possibly due to allosteric effects of the
mutations in m23 that are distant from the binding cavity.DISCUSSION
Recent experiments (6) have demonstrated that stable
mutants of certain class-A GPCRs can be engineered for
biophysical studies. We have designed a computationalBiophysical Journal 99(2) 568–577
576 Balaraman et al.method using all-atom force-field energy function and LITi-
Con, a coarse-grained conformational sampling method, to
detect stable single point mutations in GPCRs. The compu-
tational method applied to single point mutations in b1AR
showed 75% accuracy in detecting the mutations identified
in the experiments. Using LITiCon and MD simulations,
we have analyzed the mechanism behind stabilizing muta-
tions. The Y227A5.58 and V230A5.61 mutations stabilized the
receptor by increasing the propensity for salt-bridge forma-
tion between R1393.50 on TM3 and E2856.30 on TM6. The
salt bridge between TM3 and TM6, a putative signature
of the inactive state, is stabilized by these mutations and
hence contributes to an increase in stability. The mutation
F338M7.48 on TM7 alters the interaction in the conserved
motif NPxxY(x)5,6F, and hence, modulates the interaction
of TM2-TM7-helix8 microdomain. This modulation stabi-
lizes the inactivelike feature of nearly perpendicular TM7-
helix8 bend angle and smaller TM2-helix8 intracellular
distance. From these results, we infer that the increased
stability in the mutants arises due to stabilization of certain
features characteristic of the inactive state found in the
conserved microdomains. Stabilization of the inactive state
in the mutants could be the reason for their reduced constitu-
tive activity compared to the wild-type. As the thermal
stabilization in the mutants is mediated through conserved
microdomains, it was possible to transfer the thermostabiliz-
ing mutations from b1AR to b2AR as reported in a recent
work (34). Increased propensity of the D184/D186-R317
salt bridge in the extracellular loops also enhances the
stability of the inactive state in m23. However, we believe
that the interhelical contacts that stabilize the inactive and
active state conformations are different in peptide-binding
class-A GPCRs. Therefore, the stabilizing mutations could
be different in these receptors and this remains to be studied.
The LITiCon energy potential energy landscape for wild-
type and the mutant differs in shape and ruggedness around
the global minimum. The wild-type had nine minima in the
multidimensional LITiCon energy landscape, whereas the
mutants m19, m20, and m23 had four minima each and
one of these minima is the DHA-stabilized inactive state.
The stabilizing mutations in b1AR alter the global energy
landscape such that there are fewer preferred conformations
for the mutants around the inactive state in comparison to
the wild-type. Due to the presence of more minima in the
wild-type than the mutants, we speculate that at elevated
temperatures the wild-type receptor can sample multiple
conformational states and thereby reduce the receptor popu-
lation in the DHA stabilized inactive state. Hence, the wild-
type receptor could exhibit reduced DHA binding activity at
elevated temperatures. The mutants have fewer minima, and
hence populate the DHA bound conformation with higher
propensity, thereby leading to better binding to DHA at
higher temperatures. However, it is not clear whether the
b1AR mutants would melt or unfold at higher temperatures
than the wild-type b1AR.Biophysical Journal 99(2) 568–577SUPPORTING MATERIAL
Sevenfigures are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(10)00657-0.
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